Le Lézard
Classified in: Health, Science and technology
Subject: FVT

Advancing CGT Trial Ecosystems in the Asia-Pacific Region, Upcoming Webinar Hosted by Xtalks


In this free webinar, learn about the evolving landscape in cell and gene therapy (CGT) industry as well as regulatory framework in major CGT markets in the Asia-Pacific (APAC) region. Attendees will learn about navigating the complexity of CGT studies, leveraging resources on hospital infrastructure, clinicians as well as chain logistics to ease the burden of investigators and sites. The featured speakers will share insights into Fortrea's dedicated infrastructure and expertise in the CGT arena.

TORONTO, May 9, 2024 /PRNewswire-PRWeb/ -- As the frontier of the multi-disciplined scientific arena, cell and gene therapy (CGT) is unlocking its potential in treating incurable illnesses, thus changing the lives of patients. Fueled by the momentum of investment opportunities, challenges in clinical operations and market access are being experienced by the Asia-Pacific region-located biotech companies.

Fueled by the momentum of investment opportunities, challenges in clinical operations and market access are being experienced by the Asia-Pacific region-located biotech companies.

In this webinar, the attendees will get an in-depth understanding of the opportunities of CGT product development and market entry strategies in this fast-evolving industry. Attendees will gain insights into the prospect of operational excellence, investigator engagement as well as patient recruitment on accelerating the journey while exploring Fortrea's solution in navigating the complexity of clinical studies in CGT and best practices in supporting the success of both emerging biotech and large pharmaceutical sponsors.

In addition to the online presentation, feel free to book a seat at the actual site in Seoul, South Korea, to have a face-to-face discussion with Fortrea experts as well as key stakeholders covering the CGT ecosystem. In this webinar, the speakers will be sharing insights from various facets on advancing CGT clinical development in the Asia-Pacific region.

Register for this webinar today to understand the opportunities of the CGT trial ecosystem and market entry strategies for biotech companies located in the Asia-Pacific region. Participants can also book a seat to attend on-site in Seoul or Singapore on May 28 to see the live presentation and meet with Fortrea experts (information will be provided upon registering for the webinar).

Join Frederick Derosier, Vice President, Therapeutic Strategy, Clinical Lead for Enterprise Cell and Gene Therapy, Fortrea; Dong Yang, Head of Regulatory, Fortrea China; Dr. Jennifer Hollands, Government and Academic Liaison, Cell Therapies (Subsidiary of Peter MacCallum Cancer Centre); Eytan Abraham, VP, Business Head of Cell, Gene and Nucleic Acids Franchises, Resilience; and Ritu Singla, Project Manager, Fortrea, for the live webinar on Tuesday, May 28, 2024, at 3pm KST/Korea (4pm AEST/Australia).

For more information, or to register for this event, visit Advancing CGT Trial Ecosystems in the Asia-Pacific Region.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected], http://xtalks.com

SOURCE Xtalks


These press releases may also interest you

at 08:05
Autofleet, the leading optimization platform for fleets and transportation providers, announced today the launch of Autofleet Nova, the industry's first fleet specific large language model (LLM) powered by advanced AI to help fleet operators use...

at 08:05
Algolia, the world's only end-to-end AI Search solution ? helping businesses and developers understand their online users and showing them exactly what they need, today announced it was named a Leader in the inaugural 2024 Gartner® Magic Quadranttm...

at 08:05
Liongard, the global leader in Attack Surface Management (ASM), today announced Stephanie Weagle has been named Chief Marketing Officer. Weagle will report to Liongard CEO Michelle Accardi. Weagle brings over 20 years of marketing and business...

at 08:05
Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced additional favorable safety and efficacy data from the company's ongoing Phase 1b/2 clinical trial...

at 08:05
Xcell Biosciences Inc. (Xcellbio), an innovative technology company focused on cell and gene therapy manufacturing applications, and AmplifyBio, a rapidly growing contract development and manufacturing organization, today announced the launch of a...

at 08:05
DigitalOcean Holdings, Inc. , the developer cloud optimized for startups and growing technology businesses, today announced the next evolution of App Platform, a fully managed platform-as-a-service (PAAS) solution designed to streamline the entire...



News published on and distributed by: